Status:
COMPLETED
Extracorporeal Membrane Oxygenation in Coronavirus Disease (COVID-19), Influenza and ARDS of Other Ethiologies
Lead Sponsor:
University Medical Centre Ljubljana
Conditions:
ARDS
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
A comparison of clinical characteristics and outcomes of patients on extracorporeal membrane oxygenation (ECMO) in COVID-19, influenza and ARDS of other ethiologies
Detailed Description
All ARDS patients on extracorporeal membrane oxygenation (ECMO) during January 1st 2016 and January 10th 2022 in University Medical Center Ljubljana were included and their clinical characteristics an...
Eligibility Criteria
Inclusion
- Patient with acute respiratory distress syndrome (ARDS) on extracorporeal membrane oxygenation (ECMO)
- 18 years or older
Exclusion
- Patient not eligible for ECMO treatment per institutional guidelines (terminal illness, palliative care)
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05353725
Start Date
January 1 2016
End Date
March 1 2022
Last Update
May 5 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.